NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

theorysuit,

The reality of investing in any biotech is that there is almost always a very long development stage and anyone who says differently should be viewed cautiously. Traders react quickly to news that they think will get others to bite on then they dump when the buying dries up. Happens all the time because so many are hoping for the quick score but are not in position to know that they are the mark. Wise investors, not just traders, would have known that subsequent expectations being set by the Swiss news were not credible any more than Les trying to cover for the enrollment discrepancy that left out 17 SOC/placebo patients which NWBO apparently felt needed to be done to help protect the blind and ongoing collection of long term data. Biotech investing 101, believe grudgingly and carefully but when certain hold on to what others want to take away; ). Best wishes.